Dow Inc
DOW
27.77
-0.39
-1.38%
Dow Inc
US · DOW
#931 by market cap
Listed 1970
27.77
-0.39
-1.38%
Live - 5344 symbols - heartbeat 197s ago
· 2026-10-08 08:24
Pre-market
28.35
+2.09%
After-hours
27.80
+0.11%
Overnight
27.80
+0.11%
- Market cap
- 20.06B
- P/E (TTM)i
- -15.17
- P/Bi
- 1.26
- EPSi
- -3.70
- Div yieldi
- 5.04%
- 52W posi
- 36%
Reader sentiment
Are you bullish or bearish on DOW?
Anonymous reader poll. Unscientific, not investment advice.
✦ Quant Financial Health how this is computed
Weak
- Altman Z-Score is 1.57, below the 1.8 "distress zone" threshold.
- Most reliable for industrial/manufacturing companies; less meaningful for banks, insurers and other financials.
Revenue annual, last 8 years
Latest year -6.97% YoY
Margins
- Gross margin
- 6.34%
- Operating margin
- 0.40%
- Net margin
- -6.59%
Key ratios & quality
- Enterprise valuei
- 33.62B
- Altman Z-Scorei
- 1.57
Altman Z-Score below ~1.8 suggests financial distress risk, above ~3.0 suggests low risk; the model is most reliable for industrial/manufacturing companies and less meaningful for banks and other financial firms.
Income statement
| Line item | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|
| Revenue | 49.60B | 42.95B | 38.54B | 54.97B | 56.90B | 44.62B | 42.96B | 39.97B |
| Gross profit | 8.53B | 6.29B | 5.20B | 10.78B | 8.56B | 4.88B | 4.61B | 2.53B |
| Selling & admin expenses | 1.78B | 1.59B | 1.47B | 1.65B | 1.68B | 1.63B | 1.58B | 1.39B |
| Research & development | 800.00M | 765.00M | 768.00M | 857.00M | 851.00M | 829.00M | 810.00M | 752.00M |
| Operating profit | 5.48B | 3.52B | 2.56B | 7.89B | 5.70B | 2.10B | 1.91B | 158.00M |
| Pretax profit | 3.75B | -1.25B | 2.07B | 8.15B | 6.09B | 656.00M | 1.60B | -2.51B |
| Tax | 809.00M | 470.00M | 777.00M | 1.74B | 1.45B | -4.00M | 399.00M | -67.00M |
| Net profit | 4.78B | -1.27B | 1.29B | 6.41B | 4.64B | 660.00M | 1.20B | -2.44B |
| Basic EPS | 6 | -2 | 2 | 8 | 6 | 1 | 2 | -4 |
| Diluted EPS | 6.19 | -1.84 | 1.64 | 8.38 | 6.28 | 0.82 | 1.57 | -3.70 |
| Line item | 2025-03 | 2025-06 | 2025-09 | 2025-12 | 2026-03 | 2026-06 |
|---|---|---|---|---|---|---|
| Revenue | 10.43B | 10.10B | 9.97B | 9.46B | 9.79B | 12.09B |
| Gross profit | 671.00M | 583.00M | 731.00M | 548.00M | 640.00M | 2.17B |
| Selling & admin expenses | 366.00M | 347.00M | 340.00M | 339.00M | 417.00M | 535.00M |
| Research & development | 200.00M | 188.00M | 191.00M | 173.00M | 181.00M | 207.00M |
| Operating profit | 29.00M | -15.00M | 154.00M | -10.00M | -4.00M | 1.39B |
| Pretax profit | -374.00M | -659.00M | 70.00M | -1.55B | -390.00M | 871.00M |
| Tax | -84.00M | 142.00M | -54.00M | -71.00M | 55.00M | 69.00M |
| Net profit | -290.00M | -801.00M | 124.00M | -1.48B | -445.00M | 802.00M |
| Basic EPS | 0 | -1 | 0 | -2 | -1 | 1 |
| Diluted EPS | -0.44 | -1.18 | 0.08 | -2.15 | -0.74 | 0.99 |
Balance sheet
| Line item | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|
| Total current assets | 39.37B | 16.82B | 19.08B | 20.85B | 20.48B | 17.61B | 16.59B | 18.06B |
| Cash & ST investments | 2.82B | 2.37B | 5.10B | 2.99B | 3.89B | 2.99B | 2.19B | 3.82B |
| Inventory | 6.90B | 6.21B | 5.70B | 7.37B | 6.99B | 6.08B | 6.54B | 6.60B |
| Total assets | 83.70B | 60.52B | 61.47B | 62.99B | 60.60B | 57.97B | 57.31B | 58.54B |
| Total current liabilities | 15.55B | 10.68B | 11.11B | 13.23B | 11.33B | 9.96B | 10.29B | 9.18B |
| Short-term debt | 636.00M | 1.44B | 1.03B | 706.00M | 1.01B | 508.00M | 950.00M | 652.00M |
| Long-term debt | 19.25B | 15.98B | 15.97B | 13.41B | 13.91B | 14.03B | 14.77B | 16.72B |
| Total liabilities | 50,078,000,000.00 | 46,430,000,000.00 | 48,465,000,000.00 | 44,251,000,000.00 | 39,356,000,000.00 | 38,859,000,000.00 | 39,461,000,000.00 | 41,016,000,000.00 |
| Total equity | 33.62B | 14.09B | 13.01B | 18.74B | 21.25B | 19.11B | 17.85B | 17.52B |
| Retained earnings | 35.46B | 17.05B | 16.36B | 20.62B | 23.18B | 21.77B | 20.91B | 16.78B |
| Line item | 2025-03 | 2025-06 | 2025-09 | 2025-12 | 2026-03 | 2026-06 |
|---|---|---|---|---|---|---|
| Total current assets | 16.33B | 17.71B | 19.65B | 18.06B | 19.47B | 20.87B |
| Cash & ST investments | 1.47B | 2.40B | 4.61B | 3.82B | 3.85B | 3.74B |
| Inventory | 6.77B | 6.70B | 6.68B | 6.60B | 6.78B | 7.23B |
| Total assets | 57.50B | 58.99B | 60.99B | 58.54B | 59.78B | 61.59B |
| Total current liabilities | 10.59B | 10.49B | 10.10B | 9.18B | 10.54B | 11.93B |
| Short-term debt | 968.00M | 875.00M | 870.00M | 652.00M | 1.23B | 1.19B |
| Long-term debt | 14.95B | 15.18B | 16.63B | 16.72B | 17.25B | 16.08B |
| Total liabilities | 40,204,000,000.00 | 40,399,000,000.00 | 41,926,000,000.00 | 41,016,000,000.00 | 43,017,000,000.00 | 44,218,000,000.00 |
| Total equity | 17.30B | 18.59B | 19.06B | 17.52B | 16.76B | 17.37B |
| Retained earnings | 20.10B | 18.77B | 18.58B | 16.78B | 15.99B | 16.46B |
Cash flow
| Line item | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|
| Operating cash flow | 4.25B | 5.93B | 6.23B | 7.01B | 7.48B | 5.20B | 2.91B | 1.03B |
| Depreciation & amortization | 2.91B | 2.94B | 2.87B | 2.84B | 2.76B | 2.61B | 2.89B | 2.83B |
| Free cash flow | 2.12B | 3.96B | 4.84B | 4.69B | 5.42B | 2.72B | -151.00M | -1.45B |
| Dividends paid | -3.71B | -2.09B | -2.07B | -2.07B | -2.01B | -1.97B | -1.97B | -1.49B |
| Stock buybacks / issuance | 112.00M | -407.00M | -17.00M | -680.00M | -2.11B | -437.00M | -328.00M | 85.00M |
| Ending cash balance | 2.72B | 2.37B | 5.10B | 2.99B | 3.89B | 2.99B | 2.19B | 3.82B |
| Line item | 2025-03 | 2025-06 | 2025-09 | 2025-12 | 2026-03 | 2026-06 |
|---|---|---|---|---|---|---|
| Operating cash flow | 91.00M | -470.00M | 1.13B | 284.00M | 1.12B | 1.33B |
| Depreciation & amortization | 714.00M | 724.00M | 688.00M | 708.00M | 719.00M | 664.00M |
| Free cash flow | -594.00M | -1.13B | 563.00M | -284.00M | 621.00M | 699.00M |
| Dividends paid | -494.00M | -496.00M | -249.00M | -251.00M | -252.00M | -253.00M |
| Stock buybacks / issuance | -- | -- | -- | 85.00M | -- | -- |
| Ending cash balance | 1.47B | 2.40B | 4.61B | 3.82B | 4.11B | 3.97B |
Returns & efficiency
| Line item | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|
| ROE %i | 17.09 | -6.76 | 9.36 | 41.04 | 23.44 | 2.94 | 6.14 | -15.79 |
| ROA %i | 5.72 | -1.98 | 1.99 | 10.09 | 7.38 | 0.98 | 1.92 | -4.55 |
| ROIC %i | 11.31 | -1.87 | 5.33 | 20.71 | 13.75 | 2.65 | 4.46 | -5.50 |
| 5-year avg ROE %i | -- | -- | -- | 12.44 | 16.83 | 14.17 | 16.59 | 11.55 |
| EBIT margin %i | 11.67 | -0.73 | 7.52 | 16.15 | 11.87 | 3.14 | 5.61 | -4.12 |
| FCF / sales %i | 2.17 | 9.22 | 12.56 | 8.52 | 9.52 | 6.09 | -- | -- |
| Current ratioi | 2.53 | 1.57 | 1.72 | 1.58 | 1.81 | 1.77 | 1.61 | 1.97 |
| Quick ratioi | 0.76 | 0.93 | 1.12 | 0.95 | 1.03 | 0.96 | 0.88 | 1.14 |
| Debt / assetsi | 23.76 | 31.65 | 30.98 | 25.62 | 27.57 | 28.37 | 30.79 | 33.48 |
| LT debt / equityi | 59.27 | 130.82 | 144.85 | 84.94 | 75.76 | 85.66 | 96.20 | 118.35 |
| Interest coveragei | 6.29 | -0.34 | 3.50 | 12.14 | 10.20 | 1.88 | 2.97 | -1.90 |
| Revenue CAGR (3Y) %i | -- | -3.74 | -4.12 | 3.48 | 9.83 | 5.00 | -7.88 | -11.11 |
| Net income CAGR (3Y) %i | -- | -- | 38.11 | 10.79 | -- | -21.66 | -43.87 | -- |
| FCF CAGR (3Y) %i | -- | -- | -- | 30.32 | 11.01 | -17.48 | -- | -- |
| Line item | 2025-03 | 2025-06 | 2025-09 | 2025-12 | 2026-03 | 2026-06 |
|---|---|---|---|---|---|---|
| ROE %i | 1.60 | -5.59 | -6.39 | -15.79 | -17.85 | -7.86 |
| ROA %i | 0.48 | -1.69 | -1.90 | -4.55 | -4.88 | -2.16 |
| ROIC %i | 2.19 | -1.37 | -1.72 | -5.50 | -7.01 | -1.69 |
| 5-year avg ROE %i | -- | -- | -- | -- | -- | -- |
| EBIT margin %i | 3.77 | 0.84 | 0.29 | -4.12 | -4.22 | -0.31 |
| FCF / sales %i | -- | -- | -- | -- | -- | 3.87 |
| Current ratioi | 1.54 | 1.69 | 1.94 | 1.97 | 1.85 | 1.75 |
| Quick ratioi | 0.82 | 0.96 | 1.16 | 1.14 | 1.07 | 1.02 |
| Debt / assetsi | 31.17 | 30.69 | 32.18 | 33.48 | 32.84 | 31.55 |
| LT debt / equityi | 100.98 | 99.98 | 106.92 | 118.35 | 120.66 | 115.03 |
| Interest coveragei | 1.94 | 0.42 | 0.14 | -1.90 | -1.91 | -0.15 |
| Revenue CAGR (3Y) %i | -- | -- | -- | -- | -- | -- |
| Net income CAGR (3Y) %i | -- | -- | -- | -- | -- | -- |
| FCF CAGR (3Y) %i | -- | -- | -- | -- | -- | -- |
✦ Quant Revenue Concentration how this is computed
Lead segment, long tail
- Packaging & Specialty (Pack. & Spec) Plastics is the largest reported line at 52.80% of revenue, across 4 reported segments.
- Industrial Intermediates (Ind. Interm) & Infrastructure follows at 26.18%, so the top line still matters most but isn’t the whole story.
Revenue breakdown most recent period
Business
Packaging & Specialty (Pack. & Spec) Plastics52.80%
Industrial Intermediates (Ind. Interm) & Infrastructure26.18%
Performance (Perf) Materials & Coatings19.53%
Corporate (Corp)1.49%
Quote time 2026-10-08 08:24:39 · For reference only, not investment advice and not tailored to your situation.